Mirum Pharmaceuticals, Inc.

MIRM·NasdaqGM·Healthcare
Compare
96.97+9.94 (+11.42%)today
At close: Nov 4, 4:00 PM EST · May be delayed up to 15 min · USD

Prices may be delayed up to 15 min. Not investment advice. News volume: articles in the 4Search index each day.

Key statistics

Previous close87.03
Open83.13
Day range83.1397.26
52-week range63.23130.00
Off day high−0.30%
Off 52-week high−25.41%
Volume1.15M
Avg. volume (3M)724.47K
Market cap6.30B
EPS (TTM)-14.47
Forward P/E-570.41
P/E ratio (TTM)—
Dividend yield—
Beta (5Y)0.74
Shares outstanding64.93M
Short interest13.21% of float
Earnings dateNov 3, 2026
Analyst target153.43
Profit margin−139.18%

Against its peers

Compare in full ›
MIRM IONS TVTX ARWR BMRN RARE
Market cap 6.30B 6.67B 5.03B 8.71B 11.06B 1.69B
P/E (TTM) — — — — — —
Forward P/E -570.4 -35.0 9.9 -12.4 9.0 76.1
Price/book 16.0 15.1 222.1 18.7 1.8 -5.8
Dividend yield — — — — — —
1-year change +24.17% −45.88% +46.53% +47.68% +5.42% −47.82%
Today +11.42% −0.67% +6.09% +3.56% +2.64% +3.19%

The closest companies by business and industry (Biotechnology). Prices may be delayed up to 15 min.

Latest news

All MIRM news ›
Markets Daily·Negative

Mirum Pharmaceuticals (NASDAQ:MIRM) Announces Earnings Results

Posted by Michael Walen on Nov 3rd, 2026 Mirum Pharmaceuticals (NASDAQ:MIRM – Get Free Report) posted its quarterly earnings results on Tuesday. The company reported ($0.87) earnings per share for the quarter, missing analysts’ consensus…

TradingView·Positive

EBITDA of Miro Sciences Ltd – ASX:MSX

Miro Sciences Ltd. engages in researching and developing biomedical products targeting neurodegenerative conditions. It's research and development program is focused on developing a treatment for stroke-related brain injury and dementia or…

From the 4Search news index, newest first.

In the news

33mentions in 30 days
22with it in the headline
Positivesentiment

Finance and business coverage in the 4SEARCH.business news index: articles that name it in the headline, or in the text beside its ticker. Sentiment is the index's own reading of the latest 33 articles, not a forecast.

Market data is provided for information only and comes from free public sources. Prices may be delayed up to 15 minutes; data may be incomplete or inaccurate. Nothing on this page is investment advice or a recommendation to buy or sell any security. News and coverage analytics are drawn from the 4SEARCH.business index. Terms of use. How to use Finance